231 related articles for article (PubMed ID: 32296587)
21. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
22. The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation
Zhang J; Liang H; Yao H; Qiu Z; Chen X; Hu X; Hu J; Zheng G
Drug Dev Ind Pharm; 2019 Jul; 45(7):1052-1060. PubMed ID: 30939950
[No Abstract] [Full Text] [Related]
23. Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models.
Dacos M; Immordino B; Diroff E; Sicard G; Kosta A; Rodallec A; Giacometti S; Ciccolini J; Fanciullino R
Int J Pharm; 2024 May; 656():124091. PubMed ID: 38588758
[TBL] [Abstract][Full Text] [Related]
24. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
25. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology.
Li CL; Cui JX; Wang CX; Zhang L; Li YH; Zhang L; Xiu X; Li YF; Wei N
Int J Pharm; 2010 May; 391(1-2):230-6. PubMed ID: 20214962
[TBL] [Abstract][Full Text] [Related]
26. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
27. Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts.
Cao M; Long M; Chen Q; Lu Y; Luo Q; Zhao Y; Lu A; Ge C; Zhu L; Chen Z
Pharm Res; 2019 Jun; 36(8):121. PubMed ID: 31214786
[TBL] [Abstract][Full Text] [Related]
28. [Preparation of paraoxonase liposomes and their pharmacokinetics in rats].
Han Z; Jiang S; Fu B; Zhao M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1021-1025. PubMed ID: 29151419
[TBL] [Abstract][Full Text] [Related]
29. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
30. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
32. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
33. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
35. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
36. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
[TBL] [Abstract][Full Text] [Related]
37. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
38. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
39. Preparation, in vitro Characterization and Pharmacokinetic Study of Coenzyme Q10 Long-Circulating Liposomes.
Yang S
Drug Res (Stuttg); 2018 May; 68(5):270-279. PubMed ID: 29190857
[TBL] [Abstract][Full Text] [Related]
40. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao D; Tang S; Tong Q
Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
